Pharmafile Logo
Pharmafocus logo
Advanced Search

aspen

Showing 14 posts of 14 posts found.

800px-mono-embolex_by_danny_s

Mylan reaches agreement with Aspen for their European thrombosis business

September 8, 2020
Manufacturing and Production Mylan, aspen

Mylan has announced an agreement to acquire the intellectual property and commercialisation rights to Aspen’s thrombosis business for €641.9 million.  …

News
aspen

South Africa’s over-charging case against Aspen dissolves, remains against big names

October 6, 2017
Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

News
pounds_stacked

Regulators get aggressive on matters excessive

June 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CMA, Drug pricing, European Commission, Pfizer, aspen

Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their …

Feature

European Commission targets Aspen over 1,500% price hikes

May 16, 2017
Manufacturing and Production, Sales and Marketing European Commission, aspen

The European Commission (EC) has opened its first investigation over drug pricing following alleged hiking by pharma company Aspen, which …

News
4420456374_64a3d7e6aa

Top Ten articles in the Pharma Industry this week

September 16, 2016
Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto

As we come to the end of another week, we’re looking back at an exciting week in the industry; there …

News

AstraZeneca sells rights to anaesthetics products to Aspen for $520 million upfront

June 9, 2016
Research and Development, Sales and Marketing AstraZeneca, Licencing, anaesthetics, aspen, marketing agreement

UK drug firm AstraZeneca (LSE: AZN) on Thursday said it has agreed to sell rights for its anaesthetics portfolio to Aspen …

News

Pharma M&A trail continues as Pfizer buys slice of Dutch biotech

May 12, 2015
Sales and Marketing Endo, Pfizer, aspen, merger

Pfizer has acquired a minority equity interest in the biotech firm AM-Pharma, and secured an exclusive option to acquire the …

News
GSK image

GSK sells off stake in Aspen for $853m

March 13, 2015
Sales and Marketing Africa, China, GSK, Novartis, Singapore, aspen, merger, redfern

GlaxoSmithKline has sold off half its stake in South Africa’s Aspen Pharmacare in a move that will net the British …

News
gsk image

GSK sells off non-core assets

January 6, 2014
Sales and Marketing GSK, Suntory, aspen, lucozade, ribena

GlaxoSmithKline has completed the offloading of several of its non-core assets in moves which stand to net the pharma manufacturer …

News
GSK image

GSK makes £425 million Aspen sale

November 21, 2013
Sales and Marketing GSK, Merck, South Africa, aspen

GlaxoSmithKline has raised £425 million with the sale of 28.2 million shares that it has in Africa’s biggest drugmaker as …

News
gsk image

Aspen buys GSK plant and thrombosis drugs for $1.1 billion

October 1, 2013
Manufacturing and Production, Sales and Marketing GSK, aspen

South African drugmaker Aspen Pharmacare has signed another combined brand and manufacturing facility deal, this time taking on GlaxoSmithKline’s thrombosis …

News
Merck image

Aspen buys Merck facility and products in $1 billion deal

July 1, 2013
Manufacturing and Production MSD, Merck, Oss, aspen

Africa’s largest drugmaker Aspen Pharmacare has agreed to buy a manufacturing facility owned by Merck & Co, plus a portfolio …

News
GSK image

GSK mulling sales of thrombosis brands and facility to Aspen

June 24, 2013
Manufacturing and Production, Sales and Marketing Arixtra, GSK, aspen

GlaxoSmithKline says it is considering an offer from South African drugmaker Aspen Pharmacare to take ownership of two thrombosis drugs …

News
GSK image

GSK receives thrombosis offer

June 19, 2013
Sales and Marketing GSK, aspen, thrombosis

GlaxoSmithKline has received an offer from South African firm Aspen Global Incorporated (AGI) to buy its injectable thrombosis treatments and …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024